Joel Embiid
C/F· 7'0"· 280· Age 32
Joel Embiid
#21· PHI· C/F· 7'0"· Age 32
2025-26
Proj.
GP
38
38.6
PPG
26.9
26.9
RPG
7.7
7.7
APG
3.9
4.0
FG%
48.9
0.5
3P%
33.3
0.3
FT%
85.4
0.9
eFG%
52.7
52.7
Joel Embiid
C/F | 7'0" | 280 lbs | Age 32
2015 R1 Pick 3 | Kansas | Cameroon
$55.2M | 4 yrs | UFA 2029
All-NBA x5All-Def x3All-RookieMVP
Projections
Career Outlook
HOF
>99%
MVP
<1%
All-NBA
<1%
2025-26
Current
Proj.
GP
38
38.6
PPG
26.9
26.9
RPG
7.7
7.7
APG
3.9
4.0
Current
Proj.
FG%
48.9
48.9
3P%
33.3
33.4
FT%
85.4
85.4
eFG%
52.7
52.7
True Talent
Joel Embiid
Career Statistics
Latest Projections
| Playing Time | Box Score | Volume | Shooting % | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2029-30 28% ret. | — | 35 | 51.2 | — | 25.4 | 17.4 | 6.8 | 3.4 | 0.7 | 0.8 | 2.1 | 6.3 | 12.8 | 1.1 | 3.2 | 3.8 | 4.6 | 48.9% | 34.3% | 82.3% |
| 2028-29 18% ret. | — | 34 | 51.8 | — | 26.8 | 19.7 | 7.0 | 3.7 | 0.7 | 0.8 | 2.3 | 7.0 | 14.2 | 1.1 | 3.3 | 4.6 | 5.5 | 49.4% | 34.3% | 82.8% |
| 2027-28 10% ret. | — | 33 | 51.1 | — | 28.4 | 21.9 | 7.4 | 3.8 | 0.7 | 0.9 | 2.6 | 7.6 | 15.4 | 1.2 | 3.5 | 5.5 | 6.5 | 49.3% | 34.3% | 84.0% |
| 2026-27 6% ret. | — | 32 | 44.1 | — | 29.4 | 23.6 | 7.6 | 4.1 | 0.8 | 1.0 | 2.7 | 8.0 | 16.5 | 1.2 | 3.7 | 6.4 | 7.5 | 48.6% | 33.5% | 84.9% |
| 2025-26 | PHI | 31 | 38.6 | — | 31.5 | 26.9 | 7.7 | 4.0 | 0.6 | 1.2 | 2.9 | 9.0 | 18.3 | 1.4 | 4.2 | 7.5 | 8.8 | 48.9% | 33.4% | 85.4% |
| 2025-26 | PHI | 31 | 38 | 38 | 31.6 | 26.9 | 7.7 | 3.9 | 0.6 | 1.2 | 2.9 | 9.0 | 18.3 | 1.4 | 4.2 | 7.5 | 8.8 | 48.9% | 33.3% | 85.4% |
| 2024-25 | PHI | 30 | 19 | 19 | 30.2 | 23.8 | 8.2 | 4.5 | 0.7 | 0.9 | 3.3 | 7.4 | 16.6 | 1.2 | 4.1 | 7.8 | 8.9 | 44.4% | 29.9% | 88.2% |
| 2023-24 | PHI | 29 | 39 | 39 | 33.6 | 34.7 | 11.0 | 5.6 | 1.2 | 1.7 | 3.8 | 11.5 | 21.8 | 1.4 | 3.6 | 10.2 | 11.6 | 52.9% | 38.8% | 88.3% |
| 2022-23 | PHI | 28 | 66 | 66 | 34.6 | 33.1 | 10.2 | 4.2 | 1.0 | 1.7 | 3.4 | 11.0 | 20.1 | 1.0 | 3.0 | 10.0 | 11.7 | 54.8% | 33.0% | 85.7% |
| 2021-22 | PHI | 27 | 68 | 68 | 33.8 | 30.6 | 11.7 | 4.2 | 1.1 | 1.5 | 3.1 | 9.8 | 19.6 | 1.4 | 3.7 | 9.6 | 11.8 | 49.9% | 37.1% | 81.4% |
| 2020-21 | PHI | 26 | 51 | 51 | 31.1 | 28.5 | 10.6 | 2.8 | 1.0 | 1.4 | 3.1 | 9.0 | 17.6 | 1.1 | 3.0 | 9.2 | 10.7 | 51.3% | 37.7% | 85.9% |
| 2019-20 | PHI | 25 | 51 | 51 | 29.5 | 23.0 | 11.6 | 3.0 | 0.9 | 1.3 | 3.1 | 7.5 | 15.7 | 1.1 | 3.4 | 6.9 | 8.5 | 47.7% | 33.1% | 80.7% |
| 2018-19 | PHI | 24 | 64 | 64 | 33.7 | 27.5 | 13.6 | 3.7 | 0.7 | 1.9 | 3.5 | 9.1 | 18.7 | 1.2 | 4.1 | 8.2 | 10.1 | 48.4% | 30.0% | 80.4% |
| 2017-18 | PHI | 23 | 63 | 63 | 30.4 | 22.9 | 11.0 | 3.2 | 0.6 | 1.8 | 3.7 | 8.1 | 16.8 | 1.0 | 3.4 | 5.7 | 7.4 | 48.3% | 30.8% | 76.9% |
| 2016-17 | PHI | 22 | 31 | 31 | 25.4 | 20.2 | 7.8 | 2.1 | 0.9 | 2.5 | 3.8 | 6.5 | 13.8 | 1.2 | 3.2 | 6.2 | 7.9 | 46.6% | 36.7% | 78.3% |